Your browser doesn't support javascript.
loading
Pretransplant 4ß-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.
Vanhove, Thomas; Hasan, Mahmoud; Annaert, Pieter; Oswald, Stefan; Kuypers, Dirk R J.
  • Vanhove T; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium.
  • Hasan M; Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
  • Annaert P; Department of Clinical Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Hospital Greifswald, Greifswald, Germany.
  • Oswald S; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven - University of Leuven, Leuven, Belgium.
  • Kuypers DRJ; Department of Clinical Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Hospital Greifswald, Greifswald, Germany.
Br J Clin Pharmacol ; 83(11): 2406-2415, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28603840

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Tacrolimus / Biomarcadores Farmacológicos / Rechazo de Injerto / Hidroxicolesteroles / Inmunosupresores Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Tacrolimus / Biomarcadores Farmacológicos / Rechazo de Injerto / Hidroxicolesteroles / Inmunosupresores Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article